Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Autor: Guillemin F; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. francis.guillemin@univ-lorraine.fr.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital. francis.guillemin@univ-lorraine.fr., Ricatte C; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Barcenilla-Wong A; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Schoumacker A; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Cross M; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Alleyrat C; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Buttel T; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Cembalo M; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Manseur H; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Urban H; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Fautrel B; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Conaghan PG; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Hawker G; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Rutherford C; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., March L; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Spitz E; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital., Hunter DJ; From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
Jazyk: angličtina
Zdroj: The Journal of rheumatology [J Rheumatol] 2019 Sep; Vol. 46 (9), pp. 1188-1191. Date of Electronic Publication: 2019 May 15.
DOI: 10.3899/jrheum.181085
Abstrakt: Flare in knee and hip osteoarthritis (OA) is more than just an exacerbation of pain. Unstructured, semistructured, and focus group interviews followed by Delphi surveys with patients and health professionals (HP) generated candidate domains of an OA flare. Content analysis of interviews with 29 patients and 16 HP extracted 180 statements, which were grouped into 9 clusters. Delphi consensus with 50 patients (Australia, Canada, and France) and 116 HP (17 countries on 4 continents) identified 5 flare domains: pain, swelling, stiffness, psychological aspects, and effect of symptoms. Elements for a preliminary definition of an OA flare are proposed. Registered at clinicaltrials.gov NCT02892058.
Databáze: MEDLINE